Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Clinuvel Pharmaceuticals Limited has announced that Brenda Shanahan has ceased to be a director as of October 16, 2024. Shanahan’s interests in the company include shares held through various entities such as the Brenda Shanahan Superannuation Fund and the Brenda Shanahan Charitable Foundation. Investors may find these changes in directorship and shareholdings of interest when considering the company’s future direction.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.
